5 recruiting, 3 active not recruiting, 2 not yet recruiting. 9 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Recruiting 5, Active not recruiting 2, Not yet recruiting 2 |
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow AHB-137: new trials by email Literature Review of AHB-137 trials Research Report on AHB-137
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB) AHB-137, Placebo, TVAX-008 - Chronic Hepatitis B | Phase 1 / Phase 2 | Not yet recruiting | Ausper Biopharma Co., Ltd. | 105 | 2026-10-31 | 2026-10-19 |
| A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB) AHB-137, TVAX-008, Placebo - Chronic Hepatitis B | Phase 1 / Phase 2 | Not yet recruiting | Grand Theravac Life Sciences (Hangzhou) Co., Ltd. | 105 | 2026-10-31 | 2026-10-27 |
| Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions AHB-137 - Hepatitis B, Chronic | Phase 2 | Recruiting | AusperBio Therapeutics Inc. | 70 | 2026-09-01 | 2026-10-29 |
| A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B AHB-137, Placebo - Chronic Hepatitis B | Phase 2 | Recruiting | Ausper Biopharma Co., Ltd. | 320 | 2026-06-05 | 2026-07-29 |
| Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region AHB-137 - Hepatitis B, Chronic | Phase 2 | Recruiting | AusperBio Therapeutics Inc. | 84 | 2026-03-06 | 2026-10-13 |
| A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) AHB-137, NA therapy - Chronic Hepatitis B | Phase 2 | Recruiting | Ausper Biopharma Co., Ltd. | 200 | 2025-09-04 | 2026-08-05 |
| Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE) AHB-137, Placebo, NA therapy - Chronic Hepatitis B | Phase 3 | Active not recruiting | Ausper Biopharma Co., Ltd. | 577 | 2025-08-12 | 2026-05-04 |
| A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) AHB-137 - Chronic Hepatitis B | Phase 2 | Active not recruiting | Ausper Biopharma Co., Ltd. | 20 | 2025-07-15 | 2026-08-10 |
| A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs AHB-137, Peg-IFN, Hepatitis B Vaccine - Chronic Hepatitis B | Phase 2 | Recruiting | Ausper Biopharma Co., Ltd. | 200 | 2025-06-08 | 2026-07-29 |
| Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB) AHB-137, NAs, Placebo - Chronic Hepatitis B | Phase 2 | Active not recruiting | Ausper Biopharma Co., Ltd. | 105 | 2024-12-13 | 2026-07-29 |
Hepatitis B, Chronic (10) · Hepatitis B (3) · Blood-Borne Infections (2) · Chronic Disease (2) · Communicable Diseases (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Disease Attributes (2) · Hepatitis (2) · Hepatitis, Chronic (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Ausper Biopharma Co., Ltd. (7) · AusperBio Therapeutics Inc. (2) · Grand Theravac Life Sciences (Hangzhou) Co., Ltd. (1)
China (7) · Australia (1) · Canada (1) · France (1) · Italy (1) · Japan (1) · New Zealand (1) · Singapore (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Audrey Lau, MD, PhD (2) · Guiqiang Wang (2) · Yan Wang (2) · Dazhi Zhang (1) · Junqi Niu (1) · Peng Hu (1) · Yanhua Ding (1) · Yunqing Qiu (1)
2025 (1)